Skip to main content
Signal8

LifeMD, Inc. (LFMD) Form 10-Q — Nov 12, 2026

$LFMDForm 10-QFiled Nov 12, 2026, 4:58 PM ET0001493152-26-051463Original filing

LifeMD reported Q3 2026 telehealth revenue of $44.6 million, down about 6.5% from $47.7 million a year earlier, with a quarterly net loss of $4.5 million and a nine-month net loss of $20.6 million versus $5.2 million in the prior-year period. The company disclosed a revision of previously issued 2024, 2025 and 2026 financial statements to correct errors in how pharmacy-related revenue and expenses were recorded, cutting 2025 net income by $1.5 million and widening 2024 losses by $3.3 million.

Key figures

Revenue
44625086
Total Debt
0
Total Assets
66285031
Cash Position
21921769
Shares Outstanding
48333837
Avenue maturity
May 1, 2030
Q3 2025 revenue
47727942
Accounts payable
37736899
Avenue loan amount
12500000
Nine month revenue
142048848
Accumulated deficit
256343292
Atm capacity remaining
44600000
Avenue loan interest rate
greater of Prime + 4.50% or 11.50%
Active patient subscribers
350000

AI analysis

Red flags7 · Pro

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.